Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Regulator of virion expression (Rev) protein is a small (116 amino acid) regulatory protein encoded by the HIV-1 virus[1][2]. Rev is essential for HIV-1 replication because it mediates the nuclear export of unspliced and partially spliced viral mRNAs, which are necessary for the expression of structural proteins and genomic packaging[1][3][6][7]. Rev functions by binding to a structured RNA sequence in these transcripts known as the Rev response element (RRE), using an arginine-rich motif that also serves as a nuclear localization signal. Multiple Rev subunits assemble on the RRE to form a ribonucleoprotein complex that recruits the host cell nuclear export machinery, specifically the Crm1/Ran-GTP pathway, enabling the export of otherwise retained viral RNAs[2][3][5][8]. This activity is critical to the shift from early (regulatory) to late (structural) gene expression during the HIV-1 lifecycle. Rev protein activity and sequence vary among primary HIV isolates and are subject to functional modulation that may influence viral pathogenesis and immune evasion[5][6]. Rev is not an endogenous human protein, but has been a subject of basic research targeting approaches in HIV therapy[4][8].
Experimental mechanisms (not approved therapeutics) include: - Inhibiting Rev binding to the Rev response element (RRE) on viral RNA - Disrupting the oligomerization of Rev - Blocking Rev-mediated nuclear export of viral mRNA[4][8]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Regulator of virion expression (Rev) protein (Rev).